L. Wong

ERCC1, hRad51, and BRCA1 protein expression in relation to tumour response and survival of stage III/IV NSCLC patients treated with chemotherapy.

H. Groen, H. Kampinga, W. Timens, 2005, Lung cancer.

Inactivation of p16INK4a expression in malignant mesothelioma by methylation.

R. Kratzke, Joan Zhou, L. Wong, 2002, Lung cancer.

Response to the Methylation Inhibitor Dihydro-5-azacytidine in Mesothelioma Is Not Associated with Methylation of p16INK4a: Results of Cancer and Leukemia Group B 159904

E. Vokes, R. Kratzke, Mark R. Green, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.